(Q44729105)

5 December 2017

title

Estimating late adverse events using competing risks after autologous stem-cell transplantation in aggressive non-Hodgkin lymphoma patients (English)

1 reference

5 December 2017

1 reference

6

Christophe Hennequin

1 reference

5 December 2017

Rodrigo Ruiz-Soto

1

1 reference

5 December 2017

Guillaume Sergent

2

1 reference

5 December 2017

Christian Gisselbrecht

3

1 reference

5 December 2017

Jerome Larghero

4

1 reference

5 December 2017

Marjan Ertault

5

1 reference

5 December 2017

Julien Manson

7

1 reference

5 December 2017

Eric de Kerviler

8

1 reference

5 December 2017

Josette Briere

9

1 reference

5 December 2017

Nicolas Mounier

10

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

5 December 2017

number of pages

8

1 reference

inferred from page(s)

published in

Cancer

1 reference

5 December 2017

volume

104

1 reference

5 December 2017

issue

12

1 reference

5 December 2017

page(s)

2735-2742

1 reference

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

Rituximab plus CHOP (R-CHOP) overcomes bcl-2--associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

Late effects in long-term survivors of high-grade non-Hodgkin's lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

Non-Hodgkin's lymphoma: long-term survivors and adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

Outcome in Patients With Myelodysplastic Syndrome After Autologous Bone Marrow Transplantation for Non-Hodgkin's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

7 January 2021

Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

7 January 2021

Myelodysplasias and leukemias after autologous stem cell transplantation for lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21492

7 January 2021

Identifiers

DOI

10.1002/CNCR.21492

1 reference

5 December 2017

1 reference